Fig. 3
From: Impact of contrast-enhanced CT in the dosimetry of SBRT for liver metastases treated with MR-Linac

Synthetic CT (c) obtained from the plain CT (a) and contrast-enhanced CT (b) in transversal images for a representative patient
From: Impact of contrast-enhanced CT in the dosimetry of SBRT for liver metastases treated with MR-Linac
Synthetic CT (c) obtained from the plain CT (a) and contrast-enhanced CT (b) in transversal images for a representative patient